PharmaTher Provides Update on Psychedelic Product Programs
Ryan Allway April 15th, 2021 Psychedelics TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (“PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a specialty psychedelic pharmaceutical company, is pleased to provide an update on its psychedelic product programs as it relates to the clinical and commercial development of ketamine and... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )